Human mammaglobin: a superior marker for reverse-transcriptase PCR in detecting circulating tumor cells in breast cancer patients.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Biomarkers in Medicine

• Publication date

  2011-04-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.2217/bmm.11.20PMID 21473729
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Detection of Circulating Tumor Cells in Peripheral Blood of Breast Cancer Patients During or After Therapy Using a Multigene Real-Time RT-PCR Assay

  2012cited by this paper
• Detection of circulating tumour cells in breast cancer patients using human mammaglobin RT-PCR: association with clinical prognostic factors.

  2010cited by this paper
• Mammaglobin and maspin transcripts in blood may reflect disease progression and the effect of therapy in breast cancer.

  2010cited by this paper
• Detection of Cytokeratin 19, Human Mammaglobin, and Carcinoembryonic Antigen-Positive Circulating Tumor Cells by Three-Marker Reverse Transcription-Pcr Assay and Its Relation to Clinical Outcome in Early Breast Cancer

  2010cited by this paper
• Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT–PCR in patients with metastatic breast cancer

  2009cited by this paper
• Positive Bone Marrow Biopsy Is Associated with a Decreased Disease-Free Survival in Patients with Operable Breast Cancer

  2009cited by this paper
• Detection of human mammaglobin mRNA in serial peripheral blood samples from patients with non-metastatic breast cancer is not predictive of disease recurrence

  2009cited by this paper
• Cancer Statistics, 2009

  2009cited by this paper
• Detection of mammaglobin mRNA in peripheral blood is associated with high grade breast cancer: Interim results of a prospective cohort study

  2008cited by this paper
• Prognostic Value of the Molecular Detection of Circulating Tumor Cells Using a Multimarker Reverse Transcription-PCR Assay for Cytokeratin 19, Mammaglobin A, and HER2 in Early Breast Cancer

  2008cited by this paper
• Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer.

  2007cited by this paper
• Breast-specific expression of MGB1/mammaglobin: an examination of 480 tumors from various organs and clinicopathological analysis of MGB1-positive breast cancers

  2007cited by this paper
• Circulating tumor cells (CTCs) in peripheral blood of primary breast cancer patients

  2007cited by this paper
• Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast Cancer

  2006cited by this paper
• Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival

  2006cited by this paper
• Simultaneous detection of multiple mRNA markers CK19, CEA, c-Met, Her2/neu and hMAM with membrane array, an innovative technique with a great potential for breast cancer diagnosis.

  2006cited by this paper
• Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study.

  2006cited by this paper
• Significance, detection and markers of disseminated breast cancer cells.

  2006cited by this paper
• Detection of Mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR.

  2006cited by this paper
• Detection of circulating tumour cells in blood by quantitative real-time RT-PCR: effect of pre-analytical time

  2006cited by this paper
• Quantitative real-time RT-PCR of disseminated tumor cells in combination with immunomagnetic cell enrichment

  2006cited by this paper
• Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients.

  2006cited by this paper
• A variant of estrogen receptor-α, hER-α36: Transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling

  2006cited by this paper
• A variant of estrogen receptor-{alpha}, hER-{alpha}36: transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling.

  2006cited by this paper
• Real-time RT–PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer

  2006cited by this paper
• Identification, cloning, and expression of human estrogen receptor-α36, a novel variant of human estrogen receptor-α66

  2005cited by this paper
• Changes in Cytoskeletal Protein Composition Indicative of an Epithelial-Mesenchymal Transition in Human Micrometastatic and Primary Breast Carcinoma Cells

  2005cited by this paper
• Identification, cloning, and expression of human estrogen receptor-alpha36, a novel variant of human estrogen receptor-alpha66.

  2005cited by this paper
• Reverse transcriptase/polymerase chain reaction analysis of parathyroid hormone-related protein for the detection of tumor cell dissemination in the peripheral blood and bone marrow of patients with breast cancer

  2005cited by this paper
• Evaluation of a Panel of Tumor Markers for Molecular Detection of Circulating Cancer Cells in Women with Suspected Breast Cancer

  2005cited by this paper
• Effect of different cytokines on mammaglobin and maspin gene expression in normal leukocytes: possible relevance to the assays for the detection of micrometastatic breast cancer

  2005cited by this paper
• Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer.

  2005cited by this paper
• Human mammaglobin mRNA is a reliable molecular marker for detecting occult breast cancer cells in peripheral blood.

  2005cited by this paper
• Frequent EpCam protein expression in human carcinomas.

  2004cited by this paper
• Highly sensitive detection of the MGB1 transcript (mammaglobin) in the peripheral blood of breast cancer patients

  2004cited by this paper
• Mammaglobin is associated with low-grade, steroid receptor-positive breast tumors from postmenopausal patients, and has independent prognostic value for relapse-free survival time.

  2004cited by this paper
• Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay.

  2004cited by this paper
• Mammaglobin Expression in Leukapheresis Products Is a Predictive Marker of Poor Prognosis in Women with High-Risk Breast Cancer

  2004cited by this paper
• Circulating tumor cells, disease progression, and survival in metastatic breast cancer.

  2004cited by this paper
• Mammaglobin as a novel breast cancer biomarker: multigene reverse transcription-PCR assay and sandwich ELISA.

  2004cited by this paper
• Mammaglobin expression in leukapheresis products is a predictive marker of poor prognosis in women with high-risk breast cancer.

  2004cited by this paper
• Detection of CK19, CK20 and EGFR mRNAs in peripheral blood of carcinoma patients: correlation with clinical stage of disease.

  2003cited by this paper
• The expression of mammaglobin mRNA in peripheral blood of metastatic breast cancer patients as an adjunct to serum tumor markers.

  2003cited by this paper
• Application of a multigene reverse transcription-PCR assay for detection of mammaglobin and complementary transcribed genes in breast cancer lymph nodes.

  2002cited by this paper
• Human mammaglobin RT-PCR assay for detection of occult breast cancer cells in hematopoietic products.

  2002cited by this paper
• Detection of micrometastatic cells in breast cancer by RT-pCR for the mammaglobin gene.

  2002cited by this paper
• Mammaglobin a: a promising marker for breast cancer.

  2002cited by this paper
• Detection of epithelial messenger RNA in the plasma of breast cancer patients is associated with poor prognosis tumor characteristics.

  2001cited by this paper
• Maspin and mammaglobin genes are specific markers for RT-PCR detection of minimal residual disease in patients with breast cancer.

  2001cited by this paper
• Quantitative real‐time RT‐PCR detection of breast cancer micrometastasis using a multigene marker panel

  2001cited by this paper
• Statistical validation of the mammaglobin-nested RT-PCR assay for tumor cell detection in blood of breast cancer patients.

  2001cited by this paper
• Transcriptional Complementarity in Breast Cancer: Application to Detection of Circulating Tumor Cells

  2001cited by this paper
• Detection of MUC1-expressing mammary carcinoma cells in the peripheral blood of breast cancer patients by real-time polymerase chain reaction.

  2000cited by this paper
• Detection of circulating tumor cells in carcinoma patients by a novel epidermal growth factor receptor reverse transcription-PCR assay.

  2000cited by this paper
• Mammaglobin Gene Expression: A Superior Marker of Breast Cancer Cells in Peripheral Blood in Comparison to Epidermal-Growth-Factor Receptor and Cytokeratin-19

  2000cited by this paper
• All Human Genes of the Uteroglobin Family Are Localized on Chromosome 11q12.2 and Form a Dense Cluster

  2000cited by this paper
• Detection of mammaglobin expressing cells in blood of breast cancer patients.

  2000cited by this paper
• Mammaglobin, a potential marker of breast cancer nodal metastasis

  1999cited by this paper
• Detection of prostatic specific membrane antigen messenger RNA using immunobead reverse transcriptase polymerase chain reaction.

  1999cited by this paper
• Mammaglobin expression in primary, metastatic, and occult breast cancer.

  1999cited by this paper
• Detection of circulating mammary carcinoma cells in the peripheral blood of breast cancer patients via a nested reverse transcriptase polymerase chain reaction assay for mammaglobin mRNA.

  1999cited by this paper
• Detection and characterization of carcinoma cells in the blood.

  1998cited by this paper
• Identification of superior markers for polymerase chain reaction detection of breast cancer metastases in sentinel lymph nodes.

  1998cited by this paper
• Structure and transcriptional regulation of the human mammaglobin gene, a breast cancer associated member of the uteroglobin gene family localized to Chromosome 11q13

  1998cited by this paper
• Comparison of Molecular Cytokeratin 19 Reverse Transcriptase Polymerase Chain Reaction (CK19 RT-PCR) and Immunocytochemical Detection of Micrometastatic Breast Cancer Cells in Hematopoietic Harvests

  1997cited by this paper
• Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.

  1996cited by this paper
• Reverse transcription/polymerase chain reaction (RT/PCR) amplification of very small numbers of transcripts: the risk in misinterpreting negative results.

  1996cited by this paper
• Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer.

  1996cited by this paper
• Re: Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.

  1996cited by this paper

• Bioinformatics analysis of innovative multi-epitope vaccine utilizing MAGE-A, MAM-A, and Gal-3 for breast cancer management

  2025cites this paper
• Conjugation with S4 protein transduction domain enhances the immunogenicity of the peptide vaccine against breast cancer

  2024cites this paper
• Detección de células tumorales circulantes en mujeres con cáncer de mama temprano

  2024cites this paper
• The Enigma of Mammaglobin: Redefining the Biomarker Paradigm in Breast Carcinoma

  2023influential citation
• The overexpression of cyclin D1 is a positive prognostic factor in advanced-stage breast carcinoma cases

  2023cites this paper
• Detection of Minimal Residual Disease in the Peripheral Blood of Breast Cancer Patients, with a Multi Marker (MGB-1, MGB-2, CK-19 and NY-BR-1) Assay

  2021cites this paper
• Mammaglobin expression in tissue as a predictor of breast carcinoma aggressiveness

  2021cites this paper
• Detection of human mammaglobin mRNA in breast cancer cells among Vietnamese women

  2019influential citation
• The Correlation between Mammaglobin a mRNA Concentration in Peripheral Blood and Clinical Stages of Breast Cancer Patients at Sanglah General Hospital

  2017cites this paper
• Review: circulating tumor cells in the practice of breast cancer oncology

  2016cites this paper
• Diagnostic yield of primary circulating tumor cells in women suspected of breast cancer: the BEST (Breast Early Screening Test) study.

  2015cites this paper
• Upregulation of Human Mammaglobin Reduces Migration and Invasion of Breast Cancer Cells

  2014cites this paper
• The Clinical Utility of Circulating Tumor Cells in Breast Cancer Patients: Detection by a Quantitative Assay of h-MAM Gene Expression

  2014influential citation
• Human mammaglobin in breast cancer: a brief review of its clinical utility

  2014cites this paper
• HLA Class II tetramers reveal tissue-specific regulatory T cells that suppress T-cell responses in breast carcinoma patients

  2013cites this paper
• Electrochemical genosensor for detection of human mammaglobin in polymerase chain reaction amplification products of breast cancer patients

  2013cites this paper
• Detection of Mammaglobin mRNA in the Blood of Breast Cancer Egyptian Female Patients and Its Relation to Established Prognostic Parameters

  2013cites this paper
• Systematic Identification and Characterization of Novel Human Skin-Associated Genes Encoding Membrane and Secreted Proteins

  2013cites this paper
• Cytological , Histological Uni-and Multi-Immunohistochemical Marrow Examinations in Detecting Early Disseminated Tumor Cells in De Novo Breast Cancer Patients

  year unknowncites this paper